Financial Ratios

LASA SUPERGENERICS LTD.

NSE : LASABSE : 540702ISIN CODE : INE670X01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE24.65-0.38 (-1.52 %)
PREV CLOSE ( ) 25.03
OPEN PRICE ( ) 24.96
BID PRICE (QTY) 24.41 (101)
OFFER PRICE (QTY) 24.68 (121)
VOLUME 332
TODAY'S LOW / HIGH ( )24.40 24.96
52 WK LOW / HIGH ( )20.1 40.95
NSE24.55-0.55 (-2.19 %)
PREV CLOSE( ) 25.10
OPEN PRICE ( ) 24.20
BID PRICE (QTY) 24.40 (583)
OFFER PRICE (QTY) 24.55 (25)
VOLUME 36569
TODAY'S LOW / HIGH( ) 24.20 25.75
52 WK LOW / HIGH ( )20.6 41.2
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-7.71-1.065.600.89-5.26
   CEPS(Rs)-5.031.839.495.163.18
   DPS(Rs)0.000.250.250.000.00
   Book NAV/Share(Rs)23.6131.5139.0734.7846.05
   Tax Rate(%)8.6213.1622.7623.3925.29
Margin Ratios
   Core EBITDA Margin(%)-5.0911.6823.3317.916.52
   EBIT Margin(%)-29.38-4.4315.597.69-4.55
   Pre Tax Margin(%)-32.62-4.4814.572.83-9.50
   PAT Margin (%)-29.81-3.8911.252.17-7.09
   Cash Profit Margin (%)-19.456.6919.0712.534.29
Performance Ratios
   ROA(%)-20.71-2.5610.431.50-4.44
   ROE(%)-27.97-3.3715.172.94-10.81
   ROCE(%)-23.94-3.4117.146.77-3.73
   Asset Turnover(x)0.690.660.930.690.63
   Sales/Fixed Asset(x)0.560.600.910.780.82
   Working Capital/Sales(x)-36.946.368.51-3684.39-7.97
Efficiency Ratios
   Fixed Capital/Sales(x)1.781.681.101.291.22
   Receivable days29.6344.3531.9454.0476.45
   Inventory Days35.7838.2739.2863.1879.46
   Payable days45.3059.2475.46180.10153.49
Valuation Parameters
   PER(x)0.000.0010.7031.830.00
   PCE(x)-3.6722.766.315.517.24
   Price/Book(x)0.781.321.530.820.50
   Yield(%)0.000.600.420.000.00
   EV/Net Sales(x)0.861.551.280.940.79
   EV/Core EBITDA(x)-23.5313.005.465.2311.62
   EV/EBIT(x)-2.94-34.888.2012.28-17.44
   EV/CE(x)0.681.011.240.690.53
   M Cap / Sales0.711.521.200.690.31
Growth Ratio
   Net Sales Growth(%)-5.51-32.2421.00-1.37-30.37
   Core EBITDA Growth(%)-129.18-65.6056.89160.58-74.10
   EBIT Growth(%)-526.76-119.25145.38266.60-129.04
   PAT Growth(%)-624.41-123.41527.76130.16-197.49
   EPS Growth(%)-624.41-119.00527.76116.95-197.49
Financial Stability Ratios
   Total Debt/Equity(x)0.180.130.120.340.80
   Current Ratio(x)0.921.481.591.000.80
   Quick Ratio(x)0.591.221.160.650.51
   Interest Cover(x)-9.08-93.7415.281.58-0.92
   Total Debt/Mcap(x)0.240.120.080.421.61

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.